$SSY
SUNLINK HEALTH SYSTEMS INC

2021 Q3 Form 10-K Financial Statement

#000156459021049055 Filed on September 27, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2021
Revenue $10.53M $10.34M $40.69M
YoY Change 0.99% -3.31% -14.91%
Cost Of Revenue $4.073M $3.944M $15.61M
YoY Change 0.07% -6.36% -17.92%
Gross Profit $6.452M $6.391M $25.07M
YoY Change 1.57% -1.33% -12.92%
Gross Profit Margin 61.3% 61.84% 61.62%
Selling, General & Admin $6.030M $1.993M $17.81M
YoY Change 11.13% -66.63% -26.72%
% of Gross Profit 93.46% 31.18% 71.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $333.0K $404.0K $1.361M
YoY Change 11.0% 2.54% -6.14%
% of Gross Profit 5.16% 6.32% 5.43%
Operating Expenses $7.445M $3.403M $23.20M
YoY Change 11.54% -50.17% -20.33%
Operating Profit -$993.0K $2.988M $1.871M
YoY Change 207.43% -948.86% -668.69%
Interest Expense -$14.00K -$7.000K -$28.00K
YoY Change 100.0% 40.0% -3.45%
% of Operating Profit -0.23% -1.5%
Other Income/Expense, Net
YoY Change
Pretax Income $2.008M $4.665M $7.000M
YoY Change -790.03% -1634.54% -2513.79%
Income Tax $2.000K $110.0K $63.00K
% Of Pretax Income 0.1% 2.36% 0.9%
Net Earnings $1.939M $4.687M $6.890M
YoY Change -670.29% -790.28% -704.39%
Net Earnings / Revenue 18.42% 45.35% 16.93%
Basic Earnings Per Share $0.28 $1.00
Diluted Earnings Per Share $273.3K $659.0K $985.8K
COMMON SHARES
Basic Shares Outstanding 6.924M 6.920M 6.907M
Diluted Shares Outstanding 7.095M 6.989M

Balance Sheet

Concept 2021 Q3 2021 Q2 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.933M $9.962M $9.962M
YoY Change -21.66% -10.93% -10.93%
Cash & Equivalents $8.933M $9.962M $9.962M
Short-Term Investments
Other Short-Term Assets $2.291M $2.314M $2.314M
YoY Change -6.68% -9.54% -9.54%
Inventory $1.917M $1.890M $1.890M
Prepaid Expenses
Receivables $4.687M $4.189M $4.189M
Other Receivables $3.586M $3.586M $3.586M
Total Short-Term Assets $21.41M $21.94M $21.94M
YoY Change 6.97% 10.13% 10.13%
LONG-TERM ASSETS
Property, Plant & Equipment $6.920M $6.554M $7.805M
YoY Change 6.54% 23.1% 24.01%
Goodwill
YoY Change
Intangibles $1.220M $1.227M
YoY Change -2.15%
Long-Term Investments
YoY Change
Other Assets $649.0K $591.0K $591.0K
YoY Change 33.81% 18.2% 18.2%
Total Long-Term Assets $9.954M $9.623M $9.623M
YoY Change 20.99% 19.57% 19.57%
TOTAL ASSETS
Total Short-Term Assets $21.41M $21.94M $21.94M
Total Long-Term Assets $9.954M $9.623M $9.623M
Total Assets $31.37M $31.56M $31.56M
YoY Change 11.06% 12.85% 12.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.698M $1.096M $1.096M
YoY Change 5.2% 25.69% 25.69%
Accrued Expenses $5.296M $5.123M $5.123M
YoY Change 18.61% 11.1% 11.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $37.00K $3.009M $3.009M
YoY Change -97.36% 114.78% 114.78%
Total Short-Term Liabilities $7.545M $9.665M $9.665M
YoY Change -37.58% -15.34% -15.34%
LONG-TERM LIABILITIES
Long-Term Debt $44.00K $52.00K $52.00K
YoY Change -97.74% -97.34% -97.34%
Other Long-Term Liabilities $1.030M $131.0K $1.037M
YoY Change 495.38% -9.03% 21.29%
Total Long-Term Liabilities $1.074M $1.089M $1.089M
YoY Change -61.0% -61.27% -61.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.545M $9.665M $9.665M
Total Long-Term Liabilities $1.074M $1.089M $1.089M
Total Liabilities $8.619M $10.75M $10.75M
YoY Change -41.93% -24.42% -24.42%
SHAREHOLDERS EQUITY
Retained Earnings $6.809M
YoY Change -8506.17%
Common Stock $14.16M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.75M $20.81M $20.81M
YoY Change
Total Liabilities & Shareholders Equity $31.37M $31.56M $31.56M
YoY Change 11.06% 12.85% 12.85%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2021
OPERATING ACTIVITIES
Net Income $1.939M $4.687M $6.890M
YoY Change -670.29% -790.28% -704.39%
Depreciation, Depletion And Amortization $333.0K $404.0K $1.361M
YoY Change 11.0% 2.54% -6.14%
Cash From Operating Activities -$334.0K $167.0K $1.365M
YoY Change -141.03% -96.09% -65.61%
INVESTING ACTIVITIES
Capital Expenditures $692.0K -$1.296M $2.595M
YoY Change 16.3% 330.56% 118.99%
Acquisitions
YoY Change
Other Investing Activities $5.000K $3.000K $43.00K
YoY Change -37.5% 200.0% -92.31%
Cash From Investing Activities -$687.0K -$1.293M -$2.552M
YoY Change 17.04% 331.0% 307.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $8.000K $35.00K
YoY Change 0.0% -98.85%
Cash From Financing Activities -8.000K -10.00K -35.00K
YoY Change 0.0% -100.31% -135.35%
NET CHANGE
Cash From Operating Activities -334.0K 167.0K 1.365M
Cash From Investing Activities -687.0K -1.293M -2.552M
Cash From Financing Activities -8.000K -10.00K -35.00K
Net Change In Cash -1.029M -1.136M -1.222M
YoY Change -569.86% -115.82% -135.5%
FREE CASH FLOW
Cash From Operating Activities -$334.0K $167.0K $1.365M
Capital Expenditures $692.0K -$1.296M $2.595M
Free Cash Flow -$1.026M $1.463M -$1.230M
YoY Change -568.49% -67.99% -144.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3366000
CY2020Q2 us-gaap Assets
Assets
27971000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9962000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11184000
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
4189000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
4315000
CY2021Q2 us-gaap Inventory Net
InventoryNet
1890000
CY2020Q2 us-gaap Inventory Net
InventoryNet
1866000
CY2021Q2 ssy Employee Retention Credits Receivable Current
EmployeeRetentionCreditsReceivableCurrent
3586000
CY2020Q2 ssy Employee Retention Credits Receivable Current
EmployeeRetentionCreditsReceivableCurrent
0
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2314000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2558000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
21941000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
19923000
CY2021Q2 us-gaap Land
Land
582000
CY2020Q2 us-gaap Land
Land
582000
CY2021Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6361000
CY2020Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5363000
CY2021Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13937000
CY2020Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13804000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20880000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19749000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14326000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14425000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6554000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5324000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1227000
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1254000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1251000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
970000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
591000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
500000
CY2021Q2 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
3069000
CY2020Q2 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
2724000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1096000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
872000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3009000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1401000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1866000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1969000
CY2021Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1966000
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1411000
CY2021Q2 ssy Unearned Cares Act Funds
UnearnedCARESActFunds
437000
CY2020Q2 ssy Unearned Cares Act Funds
UnearnedCARESActFunds
4532000
CY2021Q2 us-gaap Assets
Assets
31564000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
403000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
365000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
888000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
866000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9665000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11416000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1957000
CY2021Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
31000
CY2020Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
104000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
875000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
607000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
131000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
144000
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1089000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2812000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
3463000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
3450000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10700000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10713000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6809000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-339000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20810000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13743000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31564000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27971000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2021Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000
CY2020Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000
CY2021Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6924000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6899000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6924000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6899000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40685000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47813000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13797000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
19563000
CY2021 us-gaap Supplies Expense
SuppliesExpense
989000
CY2020 us-gaap Supplies Expense
SuppliesExpense
1215000
CY2020 ssy Forgiveness Of Ppp Loans And Accrued Interest
ForgivenessOfPPPLoansAndAccruedInterest
0
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
102000
CY2021 ssy Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax
OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax
177000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021 us-gaap Profit Loss
ProfitLoss
6890000
CY2021 ssy Forgiveness Of Ppp Loans And Accrued Interest
ForgivenessOfPPPLoansAndAccruedInterest
264000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1361000
CY2021 ssy Forgiveness Of Paycheck Protection Plan Loans
ForgivenessOfPaycheckProtectionPlanLoans
264000
CY2020 ssy Forgiveness Of Paycheck Protection Plan Loans
ForgivenessOfPaycheckProtectionPlanLoans
0
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
28000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
13000
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-126000
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-400000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-150000
CY2021 ssy Increase Decrease In Employee Retention Credits Receivable
IncreaseDecreaseInEmployeeRetentionCreditsReceivable
3586000
CY2020 ssy Increase Decrease In Employee Retention Credits Receivable
IncreaseDecreaseInEmployeeRetentionCreditsReceivable
0
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
403000
CY2021 ssy Increase Decrease In Deferred Relief Funds
IncreaseDecreaseInDeferredReliefFunds
-4095000
CY2020 ssy Increase Decrease In Deferred Relief Funds
IncreaseDecreaseInDeferredReliefFunds
4532000
CY2021 ssy Increase Decrease In Accrued Sales Taxes
IncreaseDecreaseInAccruedSalesTaxes
555000
CY2020 ssy Increase Decrease In Accrued Sales Taxes
IncreaseDecreaseInAccruedSalesTaxes
569000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1365000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
43000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
559000
CY2021 ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
2595000
CY2020 ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1185000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2552000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-626000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
102000
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3234000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
35000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1222000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11184000
CY2021 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0
CY2020 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
371000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Management Estimates<font style="font-weight:normal;font-style:normal;"> &#8212;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</font></p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk<font style="font-weight:normal;font-style:normal;"> &#8212;SunLink&#8217;s Healthcare Services segment subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries&#8217; facilities and are insured under third-party agreements. Medicare and Medicaid patient accounts represent SunLink&#8217;s only significant concentrations of credit risk. For SunLink&#8217;s Healthcare Services segment, Medicare net revenues were approximately 52% and 52% of net revenues for the years ended June&#160;30, 2021 and 2020, respectively. For SunLink&#8217;s Healthcare Services segment, Medicaid was approximately 31% and 32% net revenues for the years ended June&#160;30, 2021 and 2020, respectively.&nbsp;&nbsp;</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink&#8217;s Pharmacy segment subsidiary grants unsecured credit to individual customers and institutional customers.&#160;Individual customers primarily are insured under third-party agreements, including Medicare and Medicaid, while the institutional customers are granted credit according to their determined credit risk.&#160;Medicare receivables were approximately 21% and 23% of the Pharmacy segment&#8217;s receivables at June&#160;30, 2021 and 2020, respectively, while Medicaid receivables were approximately 24% and 23% of the Pharmacy segment receivable at June&#160;30, 2021 and 2020, respectively. </p>
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
ssy Percentage To Claim Refundable Tax Credit Against Employer Share Of Social Security Tax Equal To Qualified Wages Payable To Employees
PercentageToClaimRefundableTaxCreditAgainstEmployerShareOfSocialSecurityTaxEqualToQualifiedWagesPayableToEmployees
0.70
CY2021 ssy Employee Retention Credit Qualified Wages Limited Per Employee Per Quarter
EmployeeRetentionCreditQualifiedWagesLimitedPerEmployeePerQuarter
10000
CY2021 ssy Maximum Employee Retention Credit Available Per Employee Per Quarter
MaximumEmployeeRetentionCreditAvailablePerEmployeePerQuarter
7000
CY2021 ssy Employee Retention Credit Amount
EmployeeRetentionCreditAmount
14000
CY2021 ssy Employee Retention Credit Amending Quarterly Payroll Tax Filing Amount
EmployeeRetentionCreditAmendingQuarterlyPayrollTaxFilingAmount
3586000
CY2021 ssy Overnight Repurchase Agreements Collateralized By Government Backed Securities
OvernightRepurchaseAgreementsCollateralizedByGovernmentBackedSecurities
1.02
CY2021 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2021 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
Estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2021 us-gaap Depreciation
Depreciation
1335000
CY2020 us-gaap Depreciation
Depreciation
1350000
CY2021 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
191000
CY2020 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
37000
CY2021 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-47000
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-554000
CY2021 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2020 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2021 ssy Health Care Organization Significant Change In Estimates
HealthCareOrganizationSignificantChangeInEstimates
69000
CY2020 ssy Health Care Organization Significant Change In Estimates
HealthCareOrganizationSignificantChangeInEstimates
139000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
514000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
593000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
37000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
8000
CY2021 ssy Operating Variable Lease Cost
OperatingVariableLeaseCost
2000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
553000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
601000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
36000
CY2020 ssy Operating Variable Lease Cost
OperatingVariableLeaseCost
3000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
36000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
9000
CY2021 ssy Finance Lease Cost
FinanceLeaseCost
43000
CY2020 ssy Finance Lease Cost
FinanceLeaseCost
45000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
203000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q2 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
43000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
34000
CY2020Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#DebtCurrent
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
90000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtNoncurrent
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
593000
CY2020 ssy Operating Cash Flows From Finance Lease
OperatingCashFlowsFromFinanceLease
9000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
32000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1498000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M28D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0279
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0654
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
415000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
256000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
248000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
241000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
132000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1302000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1278000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
42000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
42000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
13000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0
CY2021Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0
CY2021Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
97000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
89000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
26000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0
CY2021Q2 ssy Long Term Debt Maturities Repayments Of Principal In Year Six And After Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSixAndAfterYearSix
0
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
3061000
CY2021Q2 ssy Long Term Debt Contractual Commitments For Interest In Next Twelve Months
LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths
43000
CY2021Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Two
LongTermDebtContractualCommitmentsForInterestInYearTwo
5000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
410000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.53
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.38
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
0
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
0
CY2021Q2 ssy Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndThereafterFive
0
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
47000
CY2021Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
89000
CY2020Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
124000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3061000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3358000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3009000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1401000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
52000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1957000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3009000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
36000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
16000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0
CY2021Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Three
LongTermDebtContractualCommitmentsForInterestInYearThree
1000
CY2021Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Four
LongTermDebtContractualCommitmentsForInterestInYearFour
0
CY2021Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Five
LongTermDebtContractualCommitmentsForInterestInYearFive
0
CY2021Q2 ssy Long Term Debt Contractual Commitments For Interest In Year Six And After Year Six
LongTermDebtContractualCommitmentsForInterestInYearSixAndAfterYearSix
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
595000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
165000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
480000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.01
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.39
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.35
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.34
CY2020 ssy Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice
1.38
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 ssy Share Repurchase Average Price Per Share Paid
ShareRepurchaseAveragePricePerSharePaid
1.15
CY2021Q2 ssy Plan Expected To Pay In Pension Benefits Through Three Years
PlanExpectedToPayInPensionBenefitsThroughThreeYears
386000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-253000
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-86000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-339000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
177000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-162000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-253000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
63000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
296000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5856000
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6078000
CY2021Q2 ssy Deferred Tax Assets Depreciation Expense
DeferredTaxAssetsDepreciationExpense
-98000
CY2020Q2 ssy Deferred Tax Assets Depreciation Expense
DeferredTaxAssetsDepreciationExpense
-86000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
117000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
131000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
268000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1407000
CY2021Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
263000
CY2020Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
585000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
113000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
165000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
181000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
109000
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6700000
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8389000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6700000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8389000
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1470000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-61000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1076000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-369000
CY2021 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
188000
CY2020 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
175000
CY2021 ssy Income Tax Reconciliation Prior Year True Ups Associated With Cares Act Receipts
IncomeTaxReconciliationPriorYearTrueUpsAssociatedWithCARESActReceipts
-587000
CY2020 ssy Income Tax Reconciliation Prior Year True Ups Associated With Cares Act Receipts
IncomeTaxReconciliationPriorYearTrueUpsAssociatedWithCARESActReceipts
0
CY2021 ssy Income Tax Reconciliation Permanent Differences Relating To Cares Act Receipts
IncomeTaxReconciliationPermanentDifferencesRelatingToCARESActReceipts
-56000
CY2020 ssy Income Tax Reconciliation Permanent Differences Relating To Cares Act Receipts
IncomeTaxReconciliationPermanentDifferencesRelatingToCARESActReceipts
582000
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-34000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3000
CY2021 ssy Percentage Of Net Operating Losses Limitation Under Tax Cuts And Jobs Act
PercentageOfNetOperatingLossesLimitationUnderTaxCutsAndJobsAct
0.80
CY2021Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
15631000
CY2021 ssy Net Operating Loss Carry Forwards Expire Period
NetOperatingLossCarryForwardsExpirePeriod
2023 through fiscal 2038
CY2021Q2 ssy Plans Assets Invested In Cash And Short Term Investments
PlansAssetsInvestedInCashAndShortTermInvestments
0.43
CY2021Q2 ssy Plans Assets Invested In Equity Investments
PlansAssetsInvestedInEquityInvestments
0.42
CY2021Q2 ssy Plans Assets Invested In Fixed Income Investments
PlansAssetsInvestedInFixedIncomeInvestments
0.15
CY2021 ssy Expected Return On Investment
ExpectedReturnOnInvestment
0.04
CY2021Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
51000
CY2021Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
55000
CY2021Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
61000
CY2021Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
173000
CY2021Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
67000
CY2021 ssy Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
100000
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
132000
CY2021Q2 us-gaap Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
100000
CY2021 ssy Age Of Participants To Take Monthly Pension Benefits One
AgeOfParticipantsToTakeMonthlyPensionBenefitsOne
P65Y
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0260
CY2020 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0350
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0400
CY2020 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0400
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.0000
CY2020 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.0000
CY2020Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
1574000
CY2019Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
1390000
CY2021 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
40000
CY2020 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
47000
CY2021 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
51000
CY2020 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-168000
CY2021 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
28000
CY2020 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
31000
CY2020Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
923000
CY2019Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
827000
CY2021 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
85000
CY2020 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
-5000
CY2021 us-gaap Defined Benefit Plan Plan Assets Benefits Paid
DefinedBenefitPlanPlanAssetsBenefitsPaid
28000
CY2020 us-gaap Defined Benefit Plan Plan Assets Benefits Paid
DefinedBenefitPlanPlanAssetsBenefitsPaid
31000
CY2021Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
1080000
CY2021Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-455000
CY2020Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-651000
CY2021 ssy Unrecognized Actuarial Loss
UnrecognizedActuarialLoss
293000
CY2020 ssy Unrecognized Actuarial Loss
UnrecognizedActuarialLoss
469000
CY2021Q2 ssy Accrued Benefit Cost
AccruedBenefitCost
-162000
CY2020Q2 ssy Accrued Benefit Cost
AccruedBenefitCost
-182000
CY2021Q2 ssy Defined Benefit Plan Amounts Recognized In Accrued Benefit Cost
DefinedBenefitPlanAmountsRecognizedInAccruedBenefitCost
-162000
CY2020Q2 ssy Defined Benefit Plan Amounts Recognized In Accrued Benefit Cost
DefinedBenefitPlanAmountsRecognizedInAccruedBenefitCost
-182000
CY2021Q2 ssy Defined Benefit Plans Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax
DefinedBenefitPlansAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax
293000
CY2020Q2 ssy Defined Benefit Plans Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax
DefinedBenefitPlansAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax
469000
CY2021Q2 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-455000
CY2020Q2 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-651000
CY2021 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
0
CY2020 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
0
CY2020 ssy Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
137000
CY2021 ssy Number Of Taxing Authorities
NumberOfTaxingAuthorities
2
CY2020Q2 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
359000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2595000
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
82000
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14000

Files In Submission

Name View Source Status
0001564590-21-049055-index-headers.html Edgar Link pending
0001564590-21-049055-index.html Edgar Link pending
0001564590-21-049055.txt Edgar Link pending
0001564590-21-049055-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-10k_20210630.htm Edgar Link pending
ssy-20210630.xml Edgar Link completed
ssy-20210630.xsd Edgar Link pending
ssy-20210630_cal.xml Edgar Link unprocessable
ssy-20210630_def.xml Edgar Link unprocessable
ssy-20210630_lab.xml Edgar Link unprocessable
ssy-20210630_pre.xml Edgar Link unprocessable
ssy-ex211_16.htm Edgar Link pending
ssy-ex231_14.htm Edgar Link pending
ssy-ex311_6.htm Edgar Link pending
ssy-ex312_10.htm Edgar Link pending
ssy-ex321_9.htm Edgar Link pending
ssy-ex322_11.htm Edgar Link pending